Familial Adenomatous Polyposis Clinical Trial
Official title:
Pilot Investigation of 18F-FES PET/CT Imaging of Desmoid Tumors
This pilot clinical trial studies fluorine (F)-18 16 alpha-fluoroestradiol (18F-FES) positron emission tomography (PET)/computed tomography (CT) in imaging patients with desmoid tumors. 18F-FES binds to estrogen receptors, which are present on desmoid tumors, and gives off radiation that may be detected by PET and CT scans. The PET/CT scan forms an image that may show where tumor cells with estrogen receptors can be found in the body.
PRIMARY OBJECTIVES:
I. Establish the avidity of desmoid tumors on 18F-FES PET/CT imaging. II. Correlate 18F-FES
PET avidity with degree of estrogen receptor (ER) expression by immunohistochemistry (IHC).
OUTLINE:
Patients undergo 18F-FES PET/CT imaging over 30 minutes.
After completion of study, patients are followed up for 30 days.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05630794 -
Testing ONC201 to Prevent Colorectal Cancer
|
Phase 1 | |
Completed |
NCT02961374 -
Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer
|
Phase 2 | |
Completed |
NCT01483144 -
Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP)
|
Phase 3 | |
Completed |
NCT00641147 -
Curcumin in Treating Patients With Familial Adenomatous Polyposis
|
Phase 2 | |
Recruiting |
NCT03471403 -
Cold Snare Polypectomy for Duodenal Adenomas in Familial Adenomatous Polyposis
|
||
Not yet recruiting |
NCT04531930 -
Colorectal Adenoma Canceration in FAP
|
||
Recruiting |
NCT04678011 -
A Personalized Surveillance and Intervention Protocol for Patients With Familial Adenomatous Polyposis That Have Undergone (Procto)Colectomy
|
||
Recruiting |
NCT04677998 -
A Personalized Surveillance and Intervention Protocol for Duodenal and Gastric Polyposis in Patients With Familial Adenomatous Polyposis
|
||
Completed |
NCT00927485 -
Use of Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)
|
N/A | |
Recruiting |
NCT00253812 -
Adenoma Detection Rate:NBI, AFI, Chromoscopic or Standard Endoscopy
|
N/A | |
Withdrawn |
NCT00248053 -
Use of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis Patients
|
Phase 2 | |
Recruiting |
NCT02012699 -
Integrated Cancer Repository for Cancer Research
|
||
Completed |
NCT04674228 -
Review of Post-Study Clinical Endoscopy Reports in Follow Up to MAY2016-07-01
|
||
Completed |
NCT01656746 -
Single Incision Laparoscopic Surgery in Treating Patients With Colorectal Disease
|
N/A | |
Completed |
NCT00808743 -
Prevention of Progression of Duodenal Adenomas in Patients With Familial Adenomatous Polyposis
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT03847636 -
CryoBalloon Ablation for Treatment of Duodenal Adenomas
|
N/A | |
Not yet recruiting |
NCT05112822 -
Testing Obeticholic Acid (OCA) for Familial Adenomatous Polyposis (FAP)
|
Phase 1 | |
Recruiting |
NCT02656134 -
Small Bowel Endoscopic Evaluation in Familial Adenomatous Polyposis (FAP)
|
N/A | |
Withdrawn |
NCT01245816 -
A Trial of Low Dose Sulindac Combined With Eflornithine in Patients With Familial Adenomatous Polyposis (FAP)
|
Phase 3 | |
Recruiting |
NCT04709445 -
Perfusion Rate Assessment by Near-infrared Fluorescence in Gastrointestinal Anastomoses
|
N/A |